Vertex Pharmaceuticals Inc
Close on Nov 20, 2026Market cap $130.54BP/E 30.0Yield –
Vertex Pharmaceuticals Pay Versus Performance (PVP) by Year
Pay Versus Performance (PVP) — CEO Compensation Actually Paid (CAP) ($M) ($M)
Vertex Pharmaceuticals Pay Versus Performance (PVP): $38.2M in FY2025, down 12.4% from a year earlier.
Where the FY2025 figure comes from
“|| 2025 | $ 21,144,261 | $ 38,218,069 | $ 7,727,328 | $ 13,414,754 | $ 191.83 | $ 124.75 | $ 4.0 Billion | $ 11.97 Billion”
Source: Proxy Statement (DEF 14A) (vrtx-20260402.htm, filed 2026-04-02) ↗
Reported in DEF 14A Proxy Statements (Pay Versus Performance Table).
annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Pay Versus Performance (PVP) — CEO Compensation Actually Paid (CAP) ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 38.2 | -12.4% | Proxy Statement (DEF 14A) (vrtx-20260402.htm, filed 2026-04-02) ↗ |
| FY2024 | Dec 31, 2024 | 43.6 | -1.3% | Proxy Statement (DEF 14A) (vrtx-20260402.htm, filed 2026-04-02) ↗ |
| FY2023 | Dec 31, 2023 | 44.2 | +49.7% | Proxy Statement (DEF 14A) (vrtx-20260402.htm, filed 2026-04-02) ↗ |
| FY2022 | Dec 31, 2022 | 29.5 | +61.0% | Proxy Statement (DEF 14A) (vrtx-20260402.htm, filed 2026-04-02) ↗ |
| FY2021 | Dec 31, 2021 | 18.3 | – | Proxy Statement (DEF 14A) (vrtx-20260402.htm, filed 2026-04-02) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals Pay Versus Performance (PVP) ($M), annual FY2021–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/ceo-cap
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.
See a number that looks wrong?